Drug
Intranasal Challenge Drug
Intranasal Challenge Drug: highest development phase Phase 3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Intranasal challenge drug NCT01760473 | Phase 3 | Heroin Dependence |
Latest
No recent events.
Follow Intranasal Challenge Drug on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.